Vantas er en ny GnRH- analog tilhørende en farmakologisk klasse, der er indført til behandling af fremskreden prostatacancer for over 20 år siden.
Vantas is a new LHRH agonist and this pharmacological class was introduced for the treatment of advanced prostate cancer more than 20 years ago.